# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3895005 | 31c | CLH | = | 56 | uL/min.mg | ALA5121374 | mL.min-1.g-1 | ||||
2. | ALA3895005 | 31c | IC50 | = | 55 | nM | ALA5121373 | 7.26 | nM | Homo sapiens | ||
3. | ALA3895005 | 31c | Therm_solubility | = | 27 | ug ml-1 | ALA5121331 | ug.mL-1 | ||||
4. | ALA3895005 | 31c | Ratio IC50 | = | 10 | ALA3865197 | ||||||
5. | ALA3895005 | 31c | Ratio IC50 | = | 10 | ALA3865198 | ||||||
6. | ALA3895005 | 31c | IC50 | = | 23 | nM | ALA3865212 | 7.64 | nM | Homo sapiens | ||
7. | ALA3895005 | 31c | Activity | 0 | ALA3865231 | Non-Toxic | Rattus norvegicus | |||||
8. | ALA3895005 | 31c | Activity | = | 50 | % | ALA3865230 | % | ||||
9. | ALA3895005 | 31c | Activity | = | 100 | % | ALA3865229 | % | ||||
10. | ALA3895005 | 31c | Activity | = | 50 | % | ALA3865228 | % | ||||
11. | ALA3895005 | 31c | Ratio | = | 1.5 | ALA3865227 | ||||||
12. | ALA3895005 | 31c | Ratio | = | 0.15 | ALA3865226 | ||||||
13. | ALA3895005 | 31c | Ratio | = | 0.25 | ALA3865225 | ||||||
14. | ALA3895005 | 31c | Fu | = | 0.019 | ALA3865224 | ||||||
15. | ALA3895005 | 31c | Fu | = | 0.022 | ALA3865223 | ||||||
16. | ALA3895005 | 31c | Drug uptake | = | 494 | nM | ALA3865222 | nM | ||||
17. | ALA3895005 | 31c | BPR | = | 27 | % | ALA3865221 | % | ||||
18. | ALA3895005 | 31c | Cp(f) | = | 128 | nM | ALA3865220 | nM | ||||
19. | ALA3895005 | 31c | Drug uptake(free) | = | 35 | nM | ALA3865219 | nM | ||||
20. | ALA3895005 | 31c | BPR | = | 24 | % | ALA3865218 | % |